183 related articles for article (PubMed ID: 9437199)
1. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
2. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
Dentan C; Lesnik P; Chapman MJ; Ninio E
Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
[TBL] [Abstract][Full Text] [Related]
3. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
[TBL] [Abstract][Full Text] [Related]
4. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
6. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
7. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein.
Napoli C; Triggiani M; Palumbo G; Condorelli M; Chiariello M; Ambrosio G
Basic Res Cardiol; 1997 Apr; 92(2):96-105. PubMed ID: 9166989
[TBL] [Abstract][Full Text] [Related]
10. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
[TBL] [Abstract][Full Text] [Related]
11. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
12. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
Pritchard PH; Chonn A; Yeung CC
Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
[TBL] [Abstract][Full Text] [Related]
15. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.
Androulakis N; Durand H; Ninio E; Tsoukatos DC
J Lipid Res; 2005 Sep; 46(9):1923-32. PubMed ID: 15995176
[TBL] [Abstract][Full Text] [Related]
16. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
[TBL] [Abstract][Full Text] [Related]
17. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
[TBL] [Abstract][Full Text] [Related]
18. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
Steinbrecher UP; Pritchard PH
J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
[TBL] [Abstract][Full Text] [Related]
20. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]